
|Articles|December 15, 2016
December Peer Appendix
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The FDA Moves to Modernize Drug Manufacturing Registration
2
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
3
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
4
Overcoming Raw-Material Variability Challenges for Autologous Adoptive Cell Therapies
5




